Our robust and growing pipeline has the potential to play a critically influential role in the practice of Gut Microbiome Medicine and create significant value for patients and shareholders.
Dr. Eugene Chang’s NIH-funded lab, the Chang Lab at the University of Chicago in collaboration with The University of Chicago Duchossois Family Institute produced the GB diagnostic technology platform.
CS Therapeutic Platform Technology Pipeline:
The study is in progress.
Anastomotic Leak
SSI via Trojan Horse Mechanism
Sepsis
Colon Cancer Recurrence
Thought Leadership